GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (LTS:0H22) » Definitions » Accounts Payable

BioInvent International AB (LTS:0H22) Accounts Payable : kr0.00 Mil (As of Sep. 2024)


View and export this data going back to . Start your Free Trial

What is BioInvent International AB Accounts Payable?

BioInvent International AB's Accounts Payable for the quarter that ended in Sep. 2024 was kr0.00 Mil.

BioInvent International AB's annual Accounts Payable increased from Dec. 2021 (kr19.72 Mil) to Dec. 2022 (kr41.35 Mil) but then declined from Dec. 2022 (kr41.35 Mil) to Dec. 2023 (kr29.19 Mil).

BioInvent International AB Accounts Payable Historical Data

The historical data trend for BioInvent International AB's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioInvent International AB Accounts Payable Chart

BioInvent International AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.36 16.91 19.72 41.35 29.19

BioInvent International AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 29.19 - - -

BioInvent International AB Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

BioInvent International AB Accounts Payable Related Terms

Thank you for viewing the detailed overview of BioInvent International AB's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

BioInvent International AB Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioInvent International AB (LTS:0H22) » Definitions » Accounts Payable
Comparable Companies
OSTO:FLERIE OSTO:HNSA OSTO:GENO OSTO:XSPRAY OSTO:DMYD B OSTO:EGTX OSTO:ATORX OSTO:VICO XSAT:HAMLET B OSTO:IRLAB A OCSE:NOVO B VRTX REGN ASX:CSL XKRX:207940 ALNY XBRU:UCB XBRU:ARGX XKRX:068270 BNTX
Traded in Other Exchanges
BINV:Sweden BIX:Germany
Address
Ideongatan 1, Lund, SWE, SE-223 70
Website
https://www.bioinvent.com
BioInvent International AB is a clinical-stage biotech company. It discovers and develops novel and first-in-class immuno-modulatory antibodies for cancer therapy, with currently four drug candidates in five ongoing clinical programs in Phase 1/2 trials for the treatment of hematological cancer and solid tumors, respectively. The company's validated, proprietary F.I.R.S.T technology platform identifies both targets and the antibodies that bind to them, generating many new drug candidates to fuel the company's own clinical development pipeline and providing licensing and partnering opportunities. The company's pipeline portfolio comprises BI-1206, an antagonistic blocking antibody for the treatment of non-Hodgkin's lymphoma, and BI-1808 and BI-1910 (anti-TNFR2) for solid cancers.

BioInvent International AB Headlines

No Headlines